FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2327693359> ?p ?o ?g. }

• W2327693359 endingPage "198" @default.
• W2327693359 startingPage "190" @default.
• W2327693359 abstract "Using a selective glycine uptake inhibitor as adjunctive to second-generation antipsychotic (SGA) was hypothesized to ameliorate negative and/or cognitive symptoms in subjects with schizophrenia. Subjects with predominant persistent negative symptoms (previously stabilized ≥3 months on an SGA) were enrolled in a randomized, placebo-controlled trial to investigate adjunctive treatment with Org 25935, a selective inhibitor of type 1 glycine transporter, over 12 weeks in a flexible dose design. Org 25935 was tested at 4 to 8 mg twice daily and 12 to 16 mg twice daily versus placebo. Primary efficacy outcome was mean change from baseline in Scale for Assessment of Negative Symptoms composite score. Secondary efficacy end points were Positive and Negative Syndrome Scale total and subscale scores, depressive symptoms (Calgary Depression Scale for Schizophrenia), global functioning (Global Assessment of Functioning scale), and cognitive measures using a computerized battery (Central Nervous System Vital Signs). Responder rates were assessed post hoc. A total of 215 subjects were randomized, of which 187 (87%) completed the trial. Both dose groups of Org 25935 did not differ significantly from placebo on Scale for Assessment of Negative Symptoms, Positive and Negative Syndrome Scale (total or subscale scores), Global Assessment of Functioning, or the majority of tested cognitive domains. Org 25935 was generally well tolerated within the tested dose range, with no meaningful effects on extrapyramidal symptoms and some reports of reversible visual adverse effects. Org 25935 did not differ significantly from placebo in reducing negative symptoms or improving cognitive functioning when administered as adjunctive treatment to SGA. In our study population, Org 25935 appeared to be well tolerated in the tested dose ranges." @default.
• W2327693359 created "2016-06-24" @default.
• W2327693359 creator A5023676126 @default.
• W2327693359 creator A5029755078 @default.
• W2327693359 creator A5057339892 @default.
• W2327693359 creator A5072062423 @default.
• W2327693359 date "2014-04-01" @default.
• W2327693359 modified "2023-09-23" @default.
• W2327693359 title "The Selective Glycine Uptake Inhibitor Org 25935 as an Adjunctive Treatment to Atypical Antipsychotics in Predominant Persistent Negative Symptoms of Schizophrenia" @default.
• W2327693359 cites W1965120468 @default.
• W2327693359 cites W1969692783 @default.
• W2327693359 cites W1984486611 @default.
• W2327693359 cites W1995086395 @default.
• W2327693359 cites W2001822785 @default.
• W2327693359 cites W2006644482 @default.
• W2327693359 cites W2014608077 @default.
• W2327693359 cites W2014733434 @default.
• W2327693359 cites W2019130280 @default.
• W2327693359 cites W2021665131 @default.
• W2327693359 cites W2024355619 @default.
• W2327693359 cites W2031487114 @default.
• W2327693359 cites W2032359153 @default.
• W2327693359 cites W2047020796 @default.
• W2327693359 cites W2077138902 @default.
• W2327693359 cites W2081555808 @default.
• W2327693359 cites W2089131272 @default.
• W2327693359 cites W2089868642 @default.
• W2327693359 cites W2105650723 @default.
• W2327693359 cites W2111410851 @default.
• W2327693359 cites W2140606211 @default.
• W2327693359 cites W2156035025 @default.
• W2327693359 cites W2171111401 @default.
• W2327693359 cites W2324934416 @default.
• W2327693359 cites W33021784 @default.
• W2327693359 doi "https://doi.org/10.1097/jcp.0000000000000073" @default.
• W2327693359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24525661" @default.
• W2327693359 hasPublicationYear "2014" @default.
• W2327693359 type Work @default.
• W2327693359 sameAs 2327693359 @default.
• W2327693359 citedByCount "38" @default.
• W2327693359 countsByYear W23276933592014 @default.
• W2327693359 countsByYear W23276933592015 @default.
• W2327693359 countsByYear W23276933592016 @default.
• W2327693359 countsByYear W23276933592017 @default.
• W2327693359 countsByYear W23276933592018 @default.
• W2327693359 countsByYear W23276933592019 @default.
• W2327693359 countsByYear W23276933592020 @default.
• W2327693359 countsByYear W23276933592021 @default.
• W2327693359 countsByYear W23276933592023 @default.
• W2327693359 crossrefType "journal-article" @default.
• W2327693359 hasAuthorship W2327693359A5023676126 @default.
• W2327693359 hasAuthorship W2327693359A5029755078 @default.
• W2327693359 hasAuthorship W2327693359A5057339892 @default.
• W2327693359 hasAuthorship W2327693359A5072062423 @default.
• W2327693359 hasConcept C118552586 @default.
• W2327693359 hasConcept C126322002 @default.
• W2327693359 hasConcept C142724271 @default.
• W2327693359 hasConcept C15744967 @default.
• W2327693359 hasConcept C168563851 @default.
• W2327693359 hasConcept C197934379 @default.
• W2327693359 hasConcept C204787440 @default.
• W2327693359 hasConcept C27081682 @default.
• W2327693359 hasConcept C2776412080 @default.
• W2327693359 hasConcept C2779727114 @default.
• W2327693359 hasConcept C2780135775 @default.
• W2327693359 hasConcept C2780442968 @default.
• W2327693359 hasConcept C2780494398 @default.
• W2327693359 hasConcept C2780616385 @default.
• W2327693359 hasConcept C3018162438 @default.
• W2327693359 hasConcept C3019023267 @default.
• W2327693359 hasConcept C71924100 @default.
• W2327693359 hasConceptScore W2327693359C118552586 @default.
• W2327693359 hasConceptScore W2327693359C126322002 @default.
• W2327693359 hasConceptScore W2327693359C142724271 @default.
• W2327693359 hasConceptScore W2327693359C15744967 @default.
• W2327693359 hasConceptScore W2327693359C168563851 @default.
• W2327693359 hasConceptScore W2327693359C197934379 @default.
• W2327693359 hasConceptScore W2327693359C204787440 @default.
• W2327693359 hasConceptScore W2327693359C27081682 @default.
• W2327693359 hasConceptScore W2327693359C2776412080 @default.
• W2327693359 hasConceptScore W2327693359C2779727114 @default.
• W2327693359 hasConceptScore W2327693359C2780135775 @default.
• W2327693359 hasConceptScore W2327693359C2780442968 @default.
• W2327693359 hasConceptScore W2327693359C2780494398 @default.
• W2327693359 hasConceptScore W2327693359C2780616385 @default.
• W2327693359 hasConceptScore W2327693359C3018162438 @default.
• W2327693359 hasConceptScore W2327693359C3019023267 @default.
• W2327693359 hasConceptScore W2327693359C71924100 @default.
• W2327693359 hasIssue "2" @default.
• W2327693359 hasLocation W23276933591 @default.
• W2327693359 hasLocation W23276933592 @default.
• W2327693359 hasOpenAccess W2327693359 @default.
• W2327693359 hasPrimaryLocation W23276933591 @default.
• W2327693359 hasRelatedWork W2022180773 @default.
• W2327693359 hasRelatedWork W2044979734 @default.
• W2327693359 hasRelatedWork W2116902751 @default.
• W2327693359 hasRelatedWork W2291501000 @default.
• W2327693359 hasRelatedWork W2327693359 @default.

• next